IBD Scoring – Clario, GI Reviewers and RSIP Vision Team Up
Clario, GI Reviewers and RSIP Vision Team Up to Present a New AI Solution to Advance Clinical Trials for Inflammatory Bowel Diseases Innovative, human-level AI technology will improve efficiency and consistency of Inflammatory Bowel Disease (IBD) scoring, advancing clinical trials of novel treatments for these debilitating ailments. PHILADELPHIA, PA, Copenhagen, Denmark; San Mateo, CA; Boston, MA; & Jerusalem, Israel – March 6, 2023 – Clario, a leading healthcare research and technology company that generates the richest clinical evidence for the clinical trials industry and GI Reviewers, LLC Gastroenterology consultants and